Comparison of gene-specific DNA methylation patterns in equine induced pluripotent stem cell lines with cells derived from equine adult and fetal Tissues

Stem Cells and Development

Volumn 21, Issue 10, 2012, Pages 1803-1811

  Hackett, Catherine H ^a   Greve, Line ^b   Novakofski, Kira D ^a   Fortier, Lisa A ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CARTILAGE CELL; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FETUS; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PLURIPOTENCY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION;

ANIMALS; BONE MARROW CELLS; BRAIN; CELLS, CULTURED; CHONDROCYTES; CPG ISLANDS; DNA METHYLATION; FETUS; FIBROBLASTS; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HORSES; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SOXB1 TRANSCRIPTION FACTORS;

EQUIDAE; IPS;

EID: 84862894686     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0055     Document Type: Article

References (59)

1. Wang J, S Rao, J Chu, X Shen, DN Levasseur, TW Theunissen and SH Orkin. (2006). A protein interaction network for pluripotency of embryonic stem cells. Nature 444:364-368.
2. Keenen B and IL de la Serna. (2009). Chromatin remodeling in embryonic stem cells: regulating the balance between pluripotency and differentiation. J Cell Physiol 219:1-7.
3. Kalmar T, C Lim, P Hayward, S Munoz-Descalzo, J Nichols, J Garcia-Ojalvo and A Martinez Arias. (2009). Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. PLoS Biol 7:e1000149.
4. Kim JB, V Sebastiano, G Wu, MJ Arauzo-Bravo, P Sasse, L Gentile, K Ko, D Ruau, M Ehrich, et al. (2009). Oct4-induced pluripotency in adult neural stem cells. Cell 136:411-419.
5. Eiges R, M Schuldiner, M Drukker, O Yanuka, J Itskovitz-Eldor and N Benvenisty. (2001). Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol 11:514-518.
6. Judson RL, JE Babiarz, M Venere and R Blelloch. (2009). Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol 27:459-461.
7. Adachi K, H Suemori, SY Yasuda, N Nakatsuji and E Kawase. (2010). Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Genes Cells 15:455-470.
8. Suzuki A, A Raya, Y Kawakami, M Morita, T Matsui, K Nakashima, FH Gage, C Rodriguez-Esteban and JC Izpisua Belmonte. (2006). Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells. Proc Natl Acad Sci U S A 103:10294-10299.
9. Niwa H, K Ogawa, D Shimosato and K Adachi. (2009). A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460:118-122.
10. Rosner MH, MA Vigano, K Ozato, PM Timmons, F Poirier, PW Rigby and LM Staudt. (1990). A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345:686-692.
11. Silva J, I Chambers, S Pollard and A Smith. (2006). Nanog promotes transfer of pluripotency after cell fusion. Nature 441:997-1001.
12. Meissner A, M Wernig and R Jaenisch. (2007). Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 25:1177-1181.
13. Lin T, C Chao, S Saito, SJ Mazur, ME Murphy, E Appella and Y Xu. (2005). p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7:165-171.
14. Masui S, Y Nakatake, Y Toyooka, D Shimosato, R Yagi, K Takahashi, H Okochi, A Okuda, RMatoba, et al. (2007). Pluripotency governed by Sox2 via regulation ofOct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9:625-635.
15. Loh YH, Q Wu, JL Chew, VB Vega, W Zhang, X Chen, G Bourque, J George, B Leong, et al. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38:431-440.
16. Chickarmane V, C Troein, UA Nuber, HM Sauro and C Peterson. (2006). Transcriptional dynamics of the embryonic stem cell switch. PLoS Comput Biol 2:e123.
17. Zandstra PW, HV Le, GQ Daley, LG Griffith and DA Lauffenburger. (2000). Leukemia inhibitory factor (LIF) concentration modulates embryonic stem cell self-renewal and differentiation independently of proliferation. Biotechnol Bioeng 69:607-617.
18. Docherty SJ, OS Davis, CM Haworth, R Plomin and J Mill. (2009). Bisulfite-based epityping on pooled genomic DNA provides an accurate estimate of average group DNA methylation. Epigenetics Chromatin 2:3.
19. Jaenisch R and A Bird. (2003). Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 Suppl:245-254.
20. Weber M, I Hellmann, MB Stadler, L Ramos, S Paabo, M Rebhan and D Schubeler. (2007). Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39:457-466.
21. Meissner A, TS Mikkelsen, H Gu, M Wernig, J Hanna, A Sivachenko, X Zhang, BE Bernstein, C Nusbaum, et al. (2008). Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454:766-770.
22. Ku M, RP Koche, E Rheinbay, EM Mendenhall, M Endoh, TS Mikkelsen, A Presser, C Nusbaum, X Xie, et al. (2008). Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet 4:e1000242.
23. Mikkelsen TS, M Ku, DB Jaffe, B Issac, E Lieberman, G Giannoukos, P Alvarez, W Brockman, TK Kim, et al. (2007). Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448:553-560.
24. Whitelaw NC and E Whitelaw. (2006). How lifetimes shape epigenotype within and across generations. Hum Mol Genet 15:R131-R137.
25. Yeo S, S Jeong, J Kim, JS Han, YM Han and YK Kang. (2007). Characterization of DNA methylation change in stem cell marker genes during differentiation of human embryonic stem cells. Biochem Biophys Res Commun 359:536-542.
26. Yu XF, JH Kim, EJ Jung, JT Jeon and IK Kong. (2009). Cloning and characterization of cat POU5F1 and NANOG for identification of embryonic stem-like cells. J Reprod Dev 55:361-366.
27. Fouse SD, Y Shen, M Pellegrini, S Cole, A Meissner, L Van Neste, R Jaenisch and G Fan. (2008). Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell 2:160-169.
28. Go MJ, C Takenaka and H Ohgushi. (2008). Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities. Exp Cell Res 314:1147-1154.
29. Boquest AC, A Noer, AL Sorensen, K Vekterud and P Collas. (2007). CpG methylation profiles of endothelial cell-specific gene promoter regions in adipose tissue stem cells suggest limited differentiation potential toward the endothelial cell lineage. Stem Cells 25:852-861.
30. Boquest AC, A Noer and P Collas. (2006). Epigenetic programming of mesenchymal stem cells from human adipose tissue. Stem Cell Rev 2:319-329.
31. Noer A, AL Sorensen, AC Boquest and P Collas. (2006). Stable CpG hypomethylation of adipogenic promoters in freshly isolated, cultured, and differentiated mesenchymal stem cells from adipose tissue. Mol Biol Cell 17:3543-3556.
32. Guillot PV, C Gotherstrom, J Chan, H Kurata and NM Fisk. (2007). Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25:646-654.
33. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
34. Nagy K, HK Sung, P Zhang, S Laflamme, P Vincent, S Agha-Mohammadi, K Woltjen, C Monetti, IP Michael, LC Smith and A Nagy. (2011). Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Rev 7:693-702.
35. Hatano SY, M Tada, H Kimura, S Yamaguchi, T Kono, T Nakano, H Suemori, N Nakatsuji and T Tada. (2005). Pluripotential competence of cells associated with Nanog activity. Mech Dev 122:67-79.
36. Nixon AJ, JT Lillich, N Burton-Wurster, G Lust and HO Mohammed. (1998). Differentiated cellular function in fetal chondrocytes cultured with insulin-like growth factor-I and transforming growth factor-beta. J Orthop Res 16:531-541.
37. Radcliffe CH, MJ Flaminio and LA Fortier. (2009). Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations. Stem Cells Dev 19:269-282.
38. Hackett CH, MJ Flaminio and LA Fortier. (2010). Analysis of CD14 expression levels in putative mesenchymal progenitor cells isolated from equine bone marrow. Stem Cells Dev 20:721-735.
39. Takai D and PA Jones. (2002). Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 99:3740-3745.
40. Hattori N, Y Imao, K Nishino, N Hattori, J Ohgane, S Yagi, S Tanaka and K Shiota. (2007). Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. Genes Cells 12:387-396.
41. Boiani M and HR Scholer. (2005). Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 6:872-884.
42. Chambers I, D Colby, M Robertson, J Nichols, S Lee, S Tweedie and A Smith. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643-655.
43. Hart AH, L Hartley, M Ibrahim and L Robb. (2004). Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn 230:187-198.
44. Evsikov AV and D Solter. (2003). Comment on 'Stemness': transcriptional profiling of embryonic and adult stem cells'' and ''a stem cell molecular signature''. Science 302:393; author reply 393.
45. Fortunel NO, HH Otu, HH Ng, J Chen, X Mu, T Chevassut, X Li, M Joseph, C Bailey, et al. (2003). Comment on '''Stemness': transcriptional profiling of embryonic and adult stem cells'' and ''a stem cell molecular signature''. Science 302: 393; author reply 393.
46. Schepers U. (2003). A stem cell molecular signature: are there hallmark properties that are shared by all stem cells? Chembiochem 4:716-720.
47. Ivanova NB, JT Dimos, C Schaniel, JA Hackney, KA Moore and IR Lemischka. (2002). A stem cell molecular signature. Science 298:601-604.
48. Lu R, F Markowetz, RD Unwin, JT Leek, EM Airoldi, BD MacArthur, A Lachmann, R Rozov, A Ma'ayan, et al. (2009). Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature 462:358-362.
49. Wu da Y and Z Yao. (2005). Isolation and characterization of the murine Nanog gene promoter. Cell Res 15:317-324.
50. Zhao X, Y Ruan and CL Wei. (2008). Tackling the epigenome in the pluripotent stem cells. J Genet Genomics 35:403-412.
51. Liang J, M Wan, Y Zhang, P Gu, H Xin, SY Jung, J Qin, J Wong, AJ Cooney, D Liu and Z Songyang. (2008). Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat Cell Biol 10:731-739.
52. Yuri S, S Fujimura, K Nimura, N Takeda, Y Toyooka, Y Fujimura, H Aburatani, K Ura, H Koseki, H Niwa and R Nishinakamura. (2009). Sall4 is essential for stabilization, but not for pluripotency, of embryonic stem cells by repressing aberrant trophectoderm gene expression. Stem Cells 27:796-805.
53. Pan G, J Li, Y Zhou, H Zheng and D Pei. (2006). A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J 20:1730-1732.
54. Lister R, M Pelizzola, YS Kida, RD Hawkins, JR Nery, G Hon, J Antosiewicz-Bourget, R O'Malley, R Castanon, et al. (2011). Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471:68-73.
55. Kim K, A Doi, B Wen, K Ng, R Zhao, P Cahan, J Kim, MJ Aryee, H Ji, et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature 467:285-290.
56. Jiang Y, B Vaessen, T Lenvik, M Blackstad, M Reyes and CM Verfaillie. (2002). Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 30:896-904.
57. Breyer A, N Estharabadi, M Oki, F Ulloa, M Nelson-Holte, L Lien and Y Jiang. (2006). Multipotent adult progenitor cell isolation and culture procedures. Exp Hematol 34:1596-1601.
58. Ulloa-Montoya F, BL Kidder, KA Pauwelyn, LG Chase, A Luttun, A Crabbe, M Geraerts, AA Sharov, Y Piao, et al. (2007). Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity. Genome Biol 8:R163.
59. Kuroda Y, M Kitada, S Wakao, K Nishikawa, Y Tanimura, H Makinoshima, M Goda, H Akashi, A Inutsuka, et al. (2010). Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci U S A 107:8639-8643.